Inflamate® Modulates A1/A2-Associated Astrocyte Markers and Hepcidin-Related Iron-Regulatory Gene Expression in LPS-Stimulated Mouse Astrocytes

Background and Objectives: Brain inflammation may alter astrocyte function and disrupt iron homeostasis. Hepcidin may link inflammatory signals to intracellular iron retention. In this study, we investigated whether Inflamate®, a multi-ingredient plant-based supplement, induces changes in both A1/A2-associated markers and hepcidin-related iron regulation in an astrocyte cell model of LPS-induced inflammation. Methods: Mouse astrocytes were treated with Inflamate® before LPS stimulation and compared to vehicle-treated cells under normal and inflamed conditions. We measured the expression of inflammation, astrocyte reactivity, and iron control genes using RT-qPCR. We also measured some cellular proteins and secreted inflammation signals. Results: Inflamate® reduced expression of C3 (an A1-associated marker) and increased expression of S100A10 (an A2-associated marker). This opposing response was accompanied by decreased gene expression levels of NOS2 and IL6 under LPS stimulation. Intracellular iNOS and C3 proteins, as well as secreted IL-6 and C3a, were also reduced under inflammatory conditions. In addition to these changes, Inflamate® lowered hepcidin gene expression levels under both normal and LPS-stimulated conditions and suppressed the LPS-induced increase in FTH1 (which encodes the ferritin heavy chain). There were no treatment-related changes observed in the expression of the TFRC (transferrin receptor 1) and SLC40A1 (ferroportin) genes. These results suggest specific changes in astrocyte markers and a suppressed response in hepcidin-related iron metabolism genes. Conclusions: Inflamate® induced changes in both A1/A2-associated marker patterns and the expression of genes regulating iron metabolism in cultured astrocytes. These findings provide a basis for further study of Inflamate® in models of neuroinflammation.

Authors

Institutions

Publication Details

Journal
Nutrients
Published
2026-11-19
DOI
https://doi.org/10.3390/nu18223850
Primary Topic
Iron Metabolism and Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Inflamate® Modulates A1/A2-Associated Astrocyte Markers and Hepcidin-Related Iron-Regulatory Gene Expression in LPS-Stimulated Mouse Astrocytes

Masaki Kaneko, Chi-Fang Hsu, Hata Katsuhiko, Shion Osana et al.
2 links
Nutrients
Iron Metabolism and Disorders
article

Inflamate® Modulates A1/A2-Associated Astrocyte Markers and Hepcidin-Related Iron-Regulatory Gene Expression in LPS-Stimulated Mouse Astrocytes

Masaki Kaneko, Chi-Fang Hsu, Hata Katsuhiko, Shion Osana, Susumu Ito, Takako Fujii, Cheng-Ta Tsai
article en

Abstract

Background and Objectives: Brain inflammation may alter astrocyte function and disrupt iron homeostasis. Hepcidin may link inflammatory signals to intracellular iron retention. In this study, we investigated whether Inflamate®, a multi-ingredient plant-based supplement, induces changes in both A1/A2-associated markers and hepcidin-related iron regulation in an astrocyte cell model of LPS-induced inflammation. Methods: Mouse astrocytes were treated with Inflamate® before LPS stimulation and compared to vehicle-treated cells under normal and inflamed conditions. We measured the expression of inflammation, astrocyte reactivity, and iron control genes using RT-qPCR. We also measured some cellular proteins and secreted inflammation signals. Results: Inflamate® reduced expression of C3 (an A1-associated marker) and increased expression of S100A10 (an A2-associated marker). This opposing response was accompanied by decreased gene expression levels of NOS2 and IL6 under LPS stimulation. Intracellular iNOS and C3 proteins, as well as secreted IL-6 and C3a, were also reduced under inflammatory conditions. In addition to these changes, Inflamate® lowered hepcidin gene expression levels under both normal and LPS-stimulated conditions and suppressed the LPS-induced increase in FTH1 (which encodes the ferritin heavy chain). There were no treatment-related changes observed in the expression of the TFRC (transferrin receptor 1) and SLC40A1 (ferroportin) genes. These results suggest specific changes in astrocyte markers and a suppressed response in hepcidin-related iron metabolism genes. Conclusions: Inflamate® induced changes in both A1/A2-associated marker patterns and the expression of genes regulating iron metabolism in cultured astrocytes. These findings provide a basis for further study of Inflamate® in models of neuroinflammation.

NutrientsVol. 18(22)
Jikei University School of Medicine (JP), Kayaba Industry (Japan) (JP), Kokushikan University (JP), Tokyo University of Science (JP)
Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, RIKEN
Good health and well-being
Iron Metabolism and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon